Free Trial

MKS Instruments (MKSI) Financials

MKS Instruments logo
$67.18 -1.30 (-1.90%)
Closing price 04:00 PM Eastern
Extended Trading
$66.50 -0.68 (-1.01%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for MKS Instruments

Annual Income Statements for MKS Instruments

This table shows MKS Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
122 105 339 393 140 350 551 333 -1,841 190
Consolidated Net Income / (Loss)
122 105 339 393 140 350 551 333 -1,841 190
Net Income / (Loss) Continuing Operations
122 105 339 393 140 350 551 333 -1,841 190
Total Pre-Tax Income
159 128 448 481 178 423 665 433 -1,928 180
Total Operating Income
157 157 407 494 220 454 699 617 -1,554 498
Total Gross Profit
363 1,295 891 980 830 1,049 1,380 1,547 1,642 1,708
Total Revenue
814 1,295 1,916 2,075 1,900 2,330 2,950 3,547 3,622 3,586
Operating Revenue
814 1,295 1,916 2,075 1,900 2,330 2,950 3,547 3,622 3,586
Total Cost of Revenue
451 0.00 1,025 1,096 1,069 1,281 1,570 2,000 1,980 1,878
Operating Cost of Revenue
451 - 1,025 1,096 1,069 1,281 1,570 2,000 1,980 1,878
Total Operating Expenses
206 1,138 485 485 611 595 681 930 3,196 1,210
Selling, General & Admin Expense
129 228 290 298 330 353 385 488 675 674
Research & Development Expense
68 111 133 136 164 173 200 241 288 271
Amortization Expense
6.76 36 46 44 67 55 55 146 295 245
Other Operating Expenses / (Income)
- 731 0.49 0.40 6.60 - 0.00 0.00 2.00 5.00
Impairment Charge
- 5.00 6.72 0.00 4.70 - 0.00 0.00 1,902 0.00
Restructuring Charge
2.10 28 9.25 7.70 44 14 41 62 36 15
Other Special Charges / (Income)
- - - 0.00 -6.80 0.00 0.00 -7.00 -2.00 0.00
Total Other Income / (Expense), net
2.86 -29 41 -13 -42 -31 -34 -184 -374 -318
Interest Expense
0.14 31 31 17 44 29 25 177 364 341
Interest & Investment Income
3.00 2.56 3.02 5.80 5.40 1.00 0.00 4.00 17 21
Other Income / (Expense), net
- -1.24 69 -2.00 -3.30 -3.00 -9.00 -11 -27 2.00
Income Tax Expense
37 23 108 88 37 73 114 100 -87 -10
Basic Earnings per Share
$2.30 $1.96 $6.26 $7.22 $2.57 $6.36 $9.95 $5.57 ($27.54) $2.82
Weighted Average Basic Shares Outstanding
53.28M 53.47M 54.14M 54.41M 54.70M 55.10M 55.40M 59.70M 66.80M 67.30M
Diluted Earnings per Share
$2.28 $1.94 $6.16 $7.14 $2.55 $6.33 $9.90 $5.56 ($27.54) $2.81
Weighted Average Diluted Shares Outstanding
53.56M 54.05M 55.07M 55M 55.10M 55.30M 55.70M 59.90M 66.80M 67.60M
Weighted Average Basic & Diluted Shares Outstanding
53.20M 53.50M 54.20M 54.40M 54.87M 55.22M 55.52M 66.67M 67.06M 67.38M
Cash Dividends to Common per Share
$0.68 $0.68 $0.71 $0.78 $0.80 $0.80 $0.86 $0.88 $0.88 $0.88

Quarterly Income Statements for MKS Instruments

This table shows MKS Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
6.00 54 -42 -1,769 39 -69 15 23 62 90
Consolidated Net Income / (Loss)
6.00 54 -42 -1,769 39 -69 15 23 62 90
Net Income / (Loss) Continuing Operations
6.00 54 -42 -1,769 39 -69 15 23 62 90
Total Pre-Tax Income
40 66 -79 -1,791 22 -80 19 22 60 79
Total Operating Income
118 163 1.00 -1,696 118 23 106 127 128 137
Total Gross Profit
390 485 335 470 426 411 415 419 432 442
Total Revenue
954 1,086 794 1,003 932 893 868 887 896 935
Operating Revenue
954 1,086 794 1,003 932 893 868 887 896 935
Total Cost of Revenue
564 601 459 533 506 482 453 468 464 493
Operating Cost of Revenue
564 601 459 533 506 482 453 468 464 493
Total Operating Expenses
272 322 334 2,166 308 388 309 292 304 305
Selling, General & Admin Expense
126 169 174 172 167 162 170 161 167 176
Research & Development Expense
63 73 72 75 71 70 70 66 70 65
Amortization Expense
47 69 81 76 68 70 62 61 61 61
Restructuring Charge
36 11 7.00 16 4.00 9.00 4.00 4.00 4.00 3.00
Total Other Income / (Expense), net
-78 -97 -80 -95 -96 -103 -87 -105 -68 -58
Interest Expense
80 84 85 88 93 98 96 117 69 59
Interest & Investment Income
1.00 2.00 3.00 4.00 4.00 6.00 6.00 5.00 6.00 4.00
Other Income / (Expense), net
1.00 -15 2.00 -11 -7.00 -11 3.00 7.00 -5.00 -3.00
Income Tax Expense
34 12 -37 -22 -17 -11 4.00 -1.00 -2.00 -11
Basic Earnings per Share
$0.09 $0.57 ($0.64) ($26.47) $0.59 ($1.02) $0.22 $0.34 $0.92 $1.34
Weighted Average Basic Shares Outstanding
61M 59.70M 66.70M 66.80M 66.90M 66.80M 67M 67.30M 67.40M 67.30M
Diluted Earnings per Share
$0.09 $0.58 ($0.64) ($26.47) $0.58 ($1.01) $0.22 $0.33 $0.92 $1.34
Weighted Average Diluted Shares Outstanding
61.10M 59.90M 66.70M 66.80M 67.10M 66.80M 67.40M 67.50M 67.60M 67.60M
Weighted Average Basic & Diluted Shares Outstanding
66.51M 66.67M 66.77M 66.86M 66.88M 67.06M 67.20M 67.29M 67.30M 67.38M

Annual Cash Flow Statements for MKS Instruments

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-78 6.34 100 309 -230 193 358 -57 -34 -161
Net Cash From Operating Activities
138 180 355 414 245 513 640 529 319 528
Net Cash From Continuing Operating Activities
138 180 355 414 245 513 640 529 319 528
Net Income / (Loss) Continuing Operations
122 105 339 393 140 350 551 333 -1,841 190
Consolidated Net Income / (Loss)
122 105 339 393 140 350 551 333 -1,841 190
Depreciation Expense
22 66 83 80 110 99 104 216 397 348
Amortization Expense
- 24 11 4.70 15 3.00 2.00 108 33 30
Non-Cash Adjustments To Reconcile Net Income
26 46 11 54 72 58 57 62 2,031 169
Changes in Operating Assets and Liabilities, net
-32 -61 -88 -117 -93 3.00 -74 -190 -301 -209
Net Cash From Investing Activities
-167 -727 23 73 -947 -202 -205 -4,552 -84 -117
Net Cash From Continuing Investing Activities
-167 -727 23 73 -947 -202 -205 -4,552 -84 -117
Purchase of Property, Plant & Equipment
-12 -19 -31 -63 -64 -85 -87 -164 -87 -118
Acquisitions
-9.91 -940 - 0.00 -989 0.00 -268 -4,473 0.00 0.00
Purchase of Investments
-386 -268 -230 -254 -246 -522 -497 -1.00 0.00 0.00
Sale of Property, Plant & Equipment
- - - 0.00 42 0.00 0.00 9.00 3.00 1.00
Sale and/or Maturity of Investments
241 500 211 389 310 405 647 77 0.00 0.00
Net Cash From Financing Activities
-47 560 -280 -178 476 -122 -65 3,971 -259 -549
Net Cash From Continuing Financing Activities
-47 560 -280 -178 476 -122 -65 3,971 -259 -549
Repayment of Debt
- -165 -258 -117 -112 -84 -15 -1,213 -415 -2,642
Payment of Dividends
-36 -36 -38 -42 -44 -44 -47 -52 -59 -59
Issuance of Debt
- 764 29 68 642 27 1.00 5,237 216 2,161
Other Financing Activities, net
2.17 -0.45 -12 -11 -11 -21 -4.00 -1.00 -1.00 -9.00
Effect of Exchange Rate Changes
-1.69 - - - - 4.00 -12 -5.00 - -23
Cash Interest Paid
0.03 21 20 15 40 26 23 110 305 268
Cash Income Taxes Paid
43 45 105 92 36 66 110 133 180 145

Quarterly Cash Flow Statements for MKS Instruments

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-181 25 -29 -123 102 16 -30 5.00 11 -147
Net Cash From Operating Activities
199 184 37 -59 160 181 67 122 163 176
Net Cash From Continuing Operating Activities
199 184 37 -59 160 181 67 122 163 176
Net Income / (Loss) Continuing Operations
6.00 54 -42 -1,770 40 -69 15 22 62 91
Consolidated Net Income / (Loss)
6.00 54 -42 -1,770 40 -69 15 22 62 91
Depreciation Expense
64 96 107 101 93 96 88 87 87 86
Amortization Expense
85 23 8.00 7.00 8.00 10 8.00 8.00 7.00 7.00
Non-Cash Adjustments To Reconcile Net Income
26 62 2.00 1,852 61 116 7.00 47 55 60
Changes in Operating Assets and Liabilities, net
18 -51 -38 -249 -42 28 -51 -42 -48 -68
Net Cash From Investing Activities
-4,499 -52 -17 -17 -16 -34 -18 -26 -22 -51
Net Cash From Continuing Investing Activities
-4,499 -52 -17 -17 -16 -34 -18 -26 -22 -51
Purchase of Property, Plant & Equipment
-26 -55 -17 -18 -18 -34 -18 -27 -22 -51
Net Cash From Financing Activities
4,139 -137 -43 -35 -38 -143 -72 -87 -144 -246
Net Cash From Continuing Financing Activities
4,139 -137 -43 -35 -38 -143 -72 -87 -144 -246
Repayment of Debt
-827 -378 -24 -21 -23 -347 -809 -1,470 -129 -234
Payment of Dividends
-13 -15 -15 -14 -15 -15 -15 -15 -14 -15
Other Financing Activities, net
- 4.00 -6.00 1.00 - 4.00 -9.00 -2.00 -1.00 3.00
Effect of Exchange Rate Changes
-20 30 -6.00 -12 -4.00 - -7.00 -4.00 14 -26

Annual Balance Sheets for MKS Instruments

This table presents MKS Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
1,273 2,212 2,414 2,614 3,416 3,904 4,540 11,495 9,118 8,590
Total Current Assets
940 999 1,236 1,464 1,434 1,804 2,147 2,794 2,696 2,474
Cash & Equivalents
228 229 334 644 415 608 966 909 875 714
Accounts Receivable
102 249 300 295 341 393 443 720 603 615
Inventories, net
153 276 339 385 462 501 577 977 991 893
Other Current Assets
18 51 54 66 106 74 85 187 227 252
Plant, Property, & Equipment, net
69 175 172 194 242 284 326 800 784 771
Total Noncurrent Assets
265 1,039 1,006 956 1,741 1,815 2,067 7,901 5,638 5,345
Goodwill
200 589 591 587 1,059 1,066 1,228 4,308 2,554 2,479
Intangible Assets
44 408 366 320 565 512 576 3,173 2,619 2,272
Other Noncurrent Operating Assets
21 32 38 39 112 230 263 420 465 594
Total Liabilities & Shareholders' Equity
1,273 2,212 2,414 2,614 3,416 3,904 4,540 11,495 9,118 8,590
Total Liabilities
112 970 825 741 1,393 1,543 1,653 7,012 6,646 6,268
Total Current Liabilities
91 237 290 263 318 374 460 952 848 775
Short-Term Debt
- 11 2.97 3.99 12 15 9.00 93 93 50
Accounts Payable
23 69 83 84 88 111 168 426 327 341
Other Current Liabilities
28 52 61 63 79 81 89 433 428 384
Total Noncurrent Liabilities
21 733 535 478 1,075 1,169 1,193 6,060 5,798 5,493
Long-Term Debt
- 601 390 344 872 815 808 4,834 4,696 4,488
Noncurrent Deferred & Payable Income Tax Liabilities
2.66 66 62 48 72 59 99 783 640 504
Noncurrent Employee Benefit Liabilities
13 45 52 56 44 50 49 138 151 141
Other Noncurrent Operating Liabilities
5.43 21 32 30 87 245 237 305 311 360
Commitments & Contingencies
0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322
Total Preferred & Common Equity
1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,161 1,242 1,589 1,873 2,023 2,361 2,887 4,483 2,472 2,322
Common Stock
745 778 790 794 864 873 907 2,142 2,195 2,067
Retained Earnings
427 495 796 1,085 1,181 1,487 1,991 2,272 373 503
Accumulated Other Comprehensive Income / (Loss)
-11 -31 3.45 -5.66 -22 0.30 -11 69 -96 -248

Quarterly Balance Sheets for MKS Instruments

This table presents MKS Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
11,372 11,366 9,230 9,140 8,931 8,863 9,023
Total Current Assets
2,791 2,748 2,728 2,775 2,661 2,648 2,668
Cash & Equivalents
884 880 757 859 845 850 861
Accounts Receivable
730 572 631 618 576 597 609
Inventories, net
961 1,058 1,036 1,009 971 938 940
Other Current Assets
215 237 303 288 268 262 258
Plant, Property, & Equipment, net
655 794 777 761 766 759 770
Total Noncurrent Assets
7,926 7,824 5,725 5,604 5,504 5,456 5,585
Goodwill
3,851 4,327 2,575 2,540 2,511 2,495 2,567
Intangible Assets
3,653 3,108 2,728 2,614 2,501 2,418 2,443
Other Noncurrent Operating Assets
422 389 422 450 492 543 575
Total Liabilities & Shareholders' Equity
11,372 11,366 9,230 9,140 8,931 8,863 9,023
Total Liabilities
7,223 6,915 6,735 6,664 6,507 6,630 6,625
Total Current Liabilities
1,011 876 835 838 721 740 781
Short-Term Debt
95 88 88 87 50 50 50
Accounts Payable
410 372 314 309 290 291 306
Other Current Liabilities
219 416 433 442 381 399 425
Total Noncurrent Liabilities
6,212 6,039 5,900 5,826 5,786 5,890 5,844
Long-Term Debt
4,893 4,837 4,819 4,787 4,692 4,832 4,758
Noncurrent Deferred & Payable Income Tax Liabilities
893 751 628 595 622 588 590
Noncurrent Employee Benefit Liabilities
131 138 143 139 148 144 154
Other Noncurrent Operating Liabilities
295 313 310 305 324 326 342
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,149 4,451 2,495 2,476 2,424 2,233 2,398
Total Preferred & Common Equity
4,149 4,451 2,495 2,476 2,424 2,233 2,398
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,149 4,451 2,495 2,476 2,424 2,233 2,398
Common Stock
2,124 2,154 2,168 2,180 2,201 2,042 2,053
Retained Earnings
2,233 2,215 431 455 373 381 428
Accumulated Other Comprehensive Income / (Loss)
-208 82 -104 -159 -150 -190 -83

Annual Metrics and Ratios for MKS Instruments

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
4.18% 59.23% 47.91% 8.31% -8.45% 22.64% 26.61% 20.24% 2.11% -0.99%
EBITDA Growth
13.23% 37.82% 130.95% 1.36% -40.83% 62.08% 43.94% 16.83% -223.76% 176.28%
EBIT Growth
15.89% -0.37% 204.81% 3.47% -56.00% 108.31% 52.99% -12.17% -360.89% 131.63%
NOPAT Growth
4.70% 7.24% 139.20% 31.01% -57.00% 116.43% 54.18% -18.07% -329.25% 148.32%
Net Income Growth
5.63% -14.30% 223.57% 15.85% -64.27% 149.29% 57.43% -39.56% -652.85% 110.32%
EPS Growth
5.56% -14.91% 217.53% 15.91% -64.29% 148.24% 56.40% -43.84% -595.32% 110.20%
Operating Cash Flow Growth
35.70% 30.23% 97.24% 16.49% -40.91% 109.82% 24.76% -17.34% -39.70% 65.52%
Free Cash Flow Firm Growth
3,273.89% -837.34% 138.13% 12.62% -309.82% 156.95% -34.56% -2,123.41% 119.13% -25.39%
Invested Capital Growth
2.67% 182.66% 0.50% 4.53% 59.28% -1.24% 13.38% 219.31% -24.87% -3.76%
Revenue Q/Q Growth
-3.63% 21.90% 5.90% -2.41% -18.63% 37.44% 3.65% 9.98% -5.06% 1.19%
EBITDA Q/Q Growth
-8.50% 48.19% 11.41% -4.64% -5.67% 16.27% 5.71% 6.04% -14.87% 14.17%
EBIT Q/Q Growth
-9.45% 33.41% 14.14% -4.75% -12.31% 22.89% 6.01% -5.90% -9.41% 32.28%
NOPAT Q/Q Growth
-7.02% 31.70% 11.01% -2.56% -11.56% 22.61% 6.02% -5.27% -9.90% -7.27%
Net Income Q/Q Growth
-6.62% 23.53% 10.47% -1.50% -17.04% 26.22% 6.89% -22.56% -7.16% 512.90%
EPS Q/Q Growth
-6.56% 23.57% 10.20% -1.24% -17.74% 26.35% 6.45% -27.51% -6.13% 510.87%
Operating Cash Flow Q/Q Growth
6.56% 5.88% 8.58% 15.23% -19.25% 15.75% 8.11% -2.04% -0.93% -0.94%
Free Cash Flow Firm Q/Q Growth
3.23% 2.96% 0.20% 18.12% -9.63% 16.70% 21.27% -5.38% 32.89% 7.56%
Invested Capital Q/Q Growth
-2.17% -0.29% 1.84% -2.41% 0.13% 0.61% 0.03% 3.01% -1.60% -3.14%
Profitability Metrics
- - - - - - - - - -
Gross Margin
44.61% 100.00% 46.53% 47.20% 43.71% 45.02% 46.78% 43.61% 45.33% 47.63%
EBITDA Margin
21.97% 19.02% 29.69% 27.79% 17.96% 23.73% 26.98% 26.22% -31.78% 24.48%
Operating Margin
19.25% 12.14% 21.22% 23.81% 11.57% 19.49% 23.69% 17.40% -42.90% 13.89%
EBIT Margin
19.25% 12.05% 24.82% 23.71% 11.40% 19.36% 23.39% 17.08% -43.65% 13.94%
Profit (Net Income) Margin
15.03% 8.09% 17.70% 18.93% 7.39% 15.02% 18.68% 9.39% -50.83% 5.30%
Tax Burden Percent
76.69% 81.90% 75.76% 81.68% 78.97% 82.74% 82.86% 76.91% 95.49% 105.56%
Interest Burden Percent
101.82% 82.02% 94.12% 97.74% 82.12% 93.79% 96.38% 71.45% 121.95% 36.00%
Effective Tax Rate
23.31% 18.10% 24.24% 18.32% 21.03% 17.26% 17.14% 23.09% 0.00% -5.56%
Return on Invested Capital (ROIC)
24.21% 13.39% 21.63% 27.64% 8.97% 15.90% 23.12% 8.50% -14.62% 8.39%
ROIC Less NNEP Spread (ROIC-NNEP)
23.86% 23.40% 367.08% 31.59% 258.02% 0.86% 46.79% 1.04% -33.61% -0.29%
Return on Net Nonoperating Assets (RNNOA)
-13.30% -4.67% 2.33% -4.94% -1.76% 0.07% -2.12% 0.53% -38.33% -0.46%
Return on Equity (ROE)
10.91% 8.72% 23.96% 22.70% 7.21% 15.97% 21.00% 9.04% -52.94% 7.93%
Cash Return on Invested Capital (CROIC)
21.58% -82.08% 21.13% 23.21% -36.75% 17.14% 10.58% -96.10% 13.79% 12.22%
Operating Return on Assets (OROA)
12.54% 8.95% 20.56% 19.57% 7.18% 12.32% 16.34% 7.56% -15.34% 5.65%
Return on Assets (ROA)
9.79% 6.01% 14.66% 15.63% 4.66% 9.56% 13.05% 4.15% -17.86% 2.15%
Return on Common Equity (ROCE)
10.91% 8.72% 23.96% 22.70% 7.21% 15.97% 21.00% 9.04% -52.94% 7.93%
Return on Equity Simple (ROE_SIMPLE)
10.53% 8.44% 21.34% 20.97% 6.94% 14.82% 19.09% 7.43% -74.47% 8.18%
Net Operating Profit after Tax (NOPAT)
120 129 308 404 174 376 579 475 -1,088 526
NOPAT Margin
14.76% 9.94% 16.08% 19.45% 9.14% 16.12% 19.63% 13.38% -30.03% 14.66%
Net Nonoperating Expense Percent (NNEP)
0.35% -10.01% -345.45% -3.95% -249.05% 15.04% -23.67% 7.46% 18.99% 8.68%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 5.04% -14.98% 7.66%
Cost of Revenue to Revenue
55.40% 0.00% 53.47% 52.80% 56.29% 54.98% 53.22% 56.39% 54.67% 52.37%
SG&A Expenses to Revenue
15.87% 17.60% 15.14% 14.37% 17.39% 15.15% 13.05% 13.76% 18.64% 18.80%
R&D to Revenue
8.40% 8.54% 6.92% 6.54% 8.64% 7.42% 6.78% 6.79% 7.95% 7.56%
Operating Expenses to Revenue
25.35% 87.86% 25.30% 23.39% 32.14% 25.54% 23.08% 26.22% 88.24% 33.74%
Earnings before Interest and Taxes (EBIT)
157 156 476 492 217 451 690 606 -1,581 500
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
179 246 569 577 341 553 796 930 -1,151 878
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.53 2.41 3.07 1.78 2.87 3.42 3.28 1.23 2.76 3.02
Price to Tangible Book Value (P/TBV)
1.94 12.23 7.72 3.46 14.49 10.33 8.73 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.18 2.31 2.54 1.61 3.05 3.47 3.21 1.56 1.88 1.95
Price to Earnings (P/E)
14.53 28.61 14.37 8.50 41.31 23.08 17.16 16.60 0.00 36.90
Dividend Yield
2.02% 1.22% 0.79% 1.26% 0.75% 0.55% 0.50% 1.06% 0.86% 0.84%
Earnings Yield
6.88% 3.50% 6.96% 11.76% 2.42% 4.33% 5.83% 6.02% 0.00% 2.71%
Enterprise Value to Invested Capital (EV/IC)
2.23 2.24 3.30 1.98 2.59 3.43 3.47 1.12 1.68 1.76
Enterprise Value to Revenue (EV/Rev)
1.38 2.45 2.46 1.43 3.24 3.46 3.13 2.69 2.96 3.02
Enterprise Value to EBITDA (EV/EBITDA)
6.26 12.90 8.29 5.14 18.04 14.58 11.60 10.26 0.00 12.34
Enterprise Value to EBIT (EV/EBIT)
7.14 20.36 9.91 6.02 28.42 17.88 13.38 15.75 0.00 21.67
Enterprise Value to NOPAT (EV/NOPAT)
9.31 24.67 15.30 7.34 35.45 21.47 15.94 20.11 0.00 20.61
Enterprise Value to Operating Cash Flow (EV/OCF)
8.09 17.64 13.27 7.16 25.17 15.72 14.42 18.04 33.64 20.52
Enterprise Value to Free Cash Flow (EV/FCFF)
10.45 0.00 15.66 8.74 0.00 19.91 34.82 0.00 10.46 14.15
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.49 0.25 0.19 0.44 0.35 0.28 1.10 1.94 1.95
Long-Term Debt to Equity
0.00 0.48 0.25 0.18 0.43 0.35 0.28 1.08 1.90 1.93
Financial Leverage
-0.56 -0.20 0.01 -0.16 -0.01 0.08 -0.05 0.51 1.14 1.61
Leverage Ratio
1.11 1.45 1.63 1.45 1.55 1.67 1.61 2.18 2.96 3.69
Compound Leverage Factor
1.13 1.19 1.54 1.42 1.27 1.57 1.55 1.55 3.61 1.33
Debt to Total Capital
0.00% 33.02% 19.83% 15.66% 30.40% 26.00% 22.06% 52.36% 65.96% 66.15%
Short-Term Debt to Total Capital
0.00% 0.59% 0.15% 0.18% 0.42% 0.45% 0.24% 0.99% 1.28% 0.73%
Long-Term Debt to Total Capital
0.00% 32.43% 19.68% 15.48% 29.99% 25.55% 21.81% 51.37% 64.67% 65.42%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 66.98% 80.17% 84.34% 69.60% 74.00% 77.94% 47.64% 34.04% 33.85%
Debt to EBITDA
0.00 2.49 0.69 0.60 2.59 1.50 1.03 5.30 -4.16 5.17
Net Debt to EBITDA
0.00 0.73 -0.28 -0.66 1.04 -0.02 -0.28 4.32 -3.40 4.36
Long-Term Debt to EBITDA
0.00 2.44 0.69 0.60 2.55 1.47 1.02 5.20 -4.08 5.11
Debt to NOPAT
0.00 4.75 1.28 0.86 5.09 2.21 1.41 10.38 -4.40 8.63
Net Debt to NOPAT
0.00 1.39 -0.52 -0.94 2.04 -0.03 -0.39 8.47 -3.60 7.27
Long-Term Debt to NOPAT
0.00 4.67 1.27 0.85 5.02 2.17 1.40 10.19 -4.32 8.54
Altman Z-Score
11.79 3.40 5.92 5.25 4.14 5.09 5.64 1.42 0.74 1.60
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
10.33 4.21 4.27 5.56 4.51 4.83 4.67 2.93 3.18 3.19
Quick Ratio
8.35 2.81 2.91 3.85 2.72 3.29 3.23 1.71 1.74 1.71
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
107 -789 301 339 -711 405 265 -5,363 1,026 766
Operating Cash Flow to CapEx
1,114.02% 941.79% 1,135.37% 657.87% 1,121.56% 603.53% 735.63% 341.29% 379.76% 451.28%
Free Cash Flow to Firm to Interest Expense
748.62 -25.79 9.71 20.06 -16.13 13.97 10.60 -30.30 2.82 2.25
Operating Cash Flow to Interest Expense
967.10 5.88 11.46 24.49 5.54 17.69 25.60 2.99 0.88 1.55
Operating Cash Flow Less CapEx to Interest Expense
880.29 5.26 10.45 20.76 5.05 14.76 22.12 2.11 0.65 1.21
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.65 0.74 0.83 0.83 0.63 0.64 0.70 0.44 0.35 0.41
Accounts Receivable Turnover
7.81 7.39 6.98 6.97 5.97 6.35 7.06 6.10 5.48 5.89
Inventory Turnover
2.93 0.00 3.33 3.03 2.53 2.66 2.91 2.57 2.01 1.99
Fixed Asset Turnover
11.49 10.64 11.06 11.33 8.71 8.86 9.67 6.30 4.57 4.61
Accounts Payable Turnover
15.72 0.00 13.49 13.17 12.42 12.87 11.27 6.73 5.26 5.62
Days Sales Outstanding (DSO)
46.72 49.40 52.30 52.40 61.15 57.48 51.70 59.84 66.66 61.99
Days Inventory Outstanding (DIO)
124.65 0.00 109.54 120.56 144.51 137.27 125.36 141.80 181.39 183.08
Days Payable Outstanding (DPO)
23.22 0.00 27.05 27.71 29.39 28.35 32.39 54.20 69.41 64.91
Cash Conversion Cycle (CCC)
148.14 49.40 134.79 145.25 176.27 166.39 144.67 147.44 178.65 180.16
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
503 1,421 1,428 1,493 2,377 2,348 2,662 8,500 6,386 6,146
Invested Capital Turnover
1.64 1.35 1.35 1.42 0.98 0.99 1.18 0.64 0.49 0.57
Increase / (Decrease) in Invested Capital
13 918 7.11 65 885 -29 314 5,838 -2,114 -240
Enterprise Value (EV)
1,119 3,177 4,713 2,961 6,154 8,065 9,231 9,545 10,730 10,834
Market Capitalization
1,777 2,998 4,874 3,342 5,800 8,078 9,456 5,528 6,816 7,010
Book Value per Share
$21.80 $23.17 $29.26 $34.70 $37.12 $42.82 $52.06 $67.41 $36.96 $34.50
Tangible Book Value per Share
$17.22 $4.58 $11.63 $17.90 $7.34 $14.19 $19.53 ($45.08) ($40.39) ($36.09)
Total Capital
1,161 1,854 1,982 2,221 2,907 3,190 3,704 9,410 7,261 6,860
Total Debt
0.00 612 393 348 884 830 817 4,927 4,789 4,538
Total Long-Term Debt
0.00 601 390 344 872 815 808 4,834 4,696 4,488
Net Debt
-658 179 -161 -381 354 -13 -225 4,017 3,914 3,824
Capital Expenditures (CapEx)
12 19 31 63 22 85 87 155 84 117
Debt-free, Cash-free Net Working Capital (DFCFNWC)
190 349 406 487 604 609 654 1,025 1,066 1,035
Debt-free Net Working Capital (DFNWC)
849 772 949 1,205 1,128 1,445 1,696 1,935 1,941 1,749
Net Working Capital (NWC)
849 761 946 1,201 1,116 1,431 1,687 1,842 1,848 1,699
Net Nonoperating Expense (NNE)
-2.19 24 -31 11 33 26 28 142 753 336
Net Nonoperating Obligations (NNO)
-658 179 -161 -381 354 -13 -225 4,017 3,914 3,824
Total Depreciation and Amortization (D&A)
22 90 93 85 125 102 106 324 430 378
Debt-free, Cash-free Net Working Capital to Revenue
23.39% 26.95% 21.19% 23.45% 31.79% 26.14% 22.17% 28.90% 29.43% 28.86%
Debt-free Net Working Capital to Revenue
104.30% 59.63% 49.55% 58.06% 59.37% 62.02% 57.49% 54.55% 53.59% 48.77%
Net Working Capital to Revenue
104.30% 58.79% 49.40% 57.87% 58.73% 61.39% 57.19% 51.93% 51.02% 47.38%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$2.30 $1.96 $6.26 $7.22 $2.57 $6.36 $9.95 $5.57 ($27.54) $2.82
Adjusted Weighted Average Basic Shares Outstanding
53.28M 53.47M 54.14M 54.41M 54.71M 55.10M 55.40M 59.70M 66.80M 67.30M
Adjusted Diluted Earnings per Share
$2.28 $1.94 $6.16 $7.14 $2.55 $6.33 $9.90 $5.56 ($27.54) $2.81
Adjusted Weighted Average Diluted Shares Outstanding
53.56M 54.05M 55.07M 54.99M 55.11M 55.30M 55.70M 59.90M 66.80M 67.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
53.24M 53.82M 54.49M 54.20M 54.87M 55.22M 55.52M 66.67M 67.06M 67.38M
Normalized Net Operating Profit after Tax (NOPAT)
122 156 320 410 207 387 613 517 267 359
Normalized NOPAT Margin
14.96% 12.02% 16.71% 19.75% 10.89% 16.62% 20.78% 14.57% 7.38% 10.01%
Pre Tax Income Margin
19.60% 9.88% 23.36% 23.18% 9.36% 18.15% 22.54% 12.21% -53.23% 5.02%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1,095.19 5.10 15.35 29.12 4.91 15.55 27.60 3.42 -4.34 1.47
NOPAT to Interest Expense
839.91 4.21 9.94 23.88 3.94 12.95 23.17 2.68 -2.99 1.54
EBIT Less CapEx to Interest Expense
1,008.38 4.47 14.34 25.40 4.42 12.62 24.12 2.55 -4.57 1.12
NOPAT Less CapEx to Interest Expense
753.10 3.58 8.93 20.16 3.44 10.02 19.69 1.81 -3.22 1.20
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
29.41% 34.69% 11.26% 10.79% 30.98% 12.57% 8.53% 15.62% -3.20% 31.05%
Augmented Payout Ratio
40.28% 36.17% 11.26% 29.88% 30.98% 12.57% 8.53% 15.62% -3.20% 31.05%

Quarterly Metrics and Ratios for MKS Instruments

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
28.57% 42.15% 7.01% 31.11% -2.31% -17.77% 9.32% -11.57% -3.86% 4.70%
EBITDA Growth
34.67% 24.77% -42.44% -941.58% -20.90% -55.81% 73.73% 114.32% 2.36% 92.37%
EBIT Growth
-30.81% -20.43% -98.31% -1,153.70% -6.72% -91.89% 3,533.33% 107.85% 10.81% 1,016.67%
NOPAT Growth
-87.28% -13.14% -99.51% -968.68% 1,081.82% -87.93% 11,854.89% 111.18% -36.77% 869.42%
Net Income Growth
-95.45% -64.24% -129.37% -1,460.77% 550.00% -227.78% 135.71% 101.30% 58.97% 230.43%
EPS Growth
-96.22% -78.44% -124.90% -1,240.95% 544.44% -274.14% 134.38% 101.25% 58.62% 232.67%
Operating Cash Flow Growth
30.07% -5.64% -9.76% -156.19% -19.60% -1.63% 81.08% 306.78% 1.88% -2.76%
Free Cash Flow Firm Growth
-2,855.82% -3,452.76% -1,992.10% -1,312.93% 135.37% 137.34% 139.61% 110.35% -85.93% -81.41%
Invested Capital Growth
210.07% 219.31% 204.26% 130.94% -21.35% -24.87% -25.60% -5.72% -2.23% -3.76%
Revenue Q/Q Growth
24.71% 13.84% -26.89% 26.32% -7.08% -4.18% -2.80% 2.19% 1.01% 4.35%
EBITDA Q/Q Growth
41.05% -0.37% -55.81% -1,455.08% 113.26% -44.34% 73.73% 11.71% -5.24% 4.61%
EBIT Q/Q Growth
-26.54% 24.37% -97.97% -57,000.00% 106.50% -89.19% 808.33% 22.94% -8.21% 8.94%
NOPAT Q/Q Growth
-87.05% 653.47% -99.48% -169,700.00% 117.62% -92.30% 419.78% 58.66% -0.38% 18.00%
Net Income Q/Q Growth
-95.38% 800.00% -177.78% -4,111.90% 102.20% -276.92% 121.74% 53.33% 169.57% 45.16%
EPS Q/Q Growth
-96.12% 544.44% -210.34% -4,035.94% 102.19% -274.14% 121.78% 50.00% 178.79% 45.65%
Operating Cash Flow Q/Q Growth
89.52% -7.54% -79.89% -259.46% 371.19% 13.13% -62.98% 82.09% 33.61% 7.98%
Free Cash Flow Firm Q/Q Growth
-1,489.41% -2.36% 0.04% 13.12% 139.79% 8.06% 6.04% -77.30% -45.93% 42.85%
Invested Capital Q/Q Growth
186.83% 3.01% -0.06% -21.79% -2.32% -1.60% -1.03% -0.89% 1.29% -3.14%
Profitability Metrics
- - - - - - - - - -
Gross Margin
40.88% 44.66% 42.19% 46.86% 45.71% 46.02% 47.81% 47.24% 48.21% 47.27%
EBITDA Margin
28.09% 24.59% 14.86% -159.42% 22.75% 13.21% 23.62% 25.82% 24.22% 24.28%
Operating Margin
12.37% 15.01% 0.13% -169.09% 12.66% 2.58% 12.21% 14.32% 14.29% 14.65%
EBIT Margin
12.47% 13.63% 0.38% -170.19% 11.91% 1.34% 12.56% 15.11% 13.73% 14.33%
Profit (Net Income) Margin
0.63% 4.97% -5.29% -176.37% 4.18% -7.73% 1.73% 2.59% 6.92% 9.63%
Tax Burden Percent
15.00% 81.82% 53.16% 98.77% 177.27% 86.25% 78.95% 104.55% 103.33% 113.92%
Interest Burden Percent
33.61% 44.59% -2,633.33% 104.92% 19.82% -666.67% 17.43% 16.42% 48.78% 58.96%
Effective Tax Rate
85.00% 18.18% 0.00% 0.00% -77.27% 0.00% 21.05% -4.55% -3.33% -13.92%
Return on Invested Capital (ROIC)
1.10% 7.80% 0.06% -95.40% 11.62% 0.88% 4.81% 8.30% 8.15% 9.55%
ROIC Less NNEP Spread (ROIC-NNEP)
0.51% 3.62% -2.19% -125.26% 7.42% -1.27% 3.08% 5.62% 6.39% 7.85%
Return on Net Nonoperating Assets (RNNOA)
0.30% 1.86% -1.11% -86.80% 9.10% -1.45% 3.56% 9.72% 10.43% 12.66%
Return on Equity (ROE)
1.39% 9.67% -1.06% -182.20% 20.71% -0.57% 8.37% 18.02% 18.58% 22.22%
Cash Return on Invested Capital (CROIC)
-93.28% -96.10% -94.66% -99.92% 10.48% 13.79% 15.67% 9.94% 11.09% 12.22%
Operating Return on Assets (OROA)
5.11% 6.03% 0.17% -93.43% 4.43% 0.47% 4.57% 5.98% 5.36% 5.80%
Return on Assets (ROA)
0.26% 2.20% -2.38% -96.82% 1.56% -2.72% 0.63% 1.03% 2.70% 3.90%
Return on Common Equity (ROCE)
1.39% 9.67% -1.06% -182.20% 20.71% -0.57% 8.37% 18.02% 18.58% 22.22%
Return on Equity Simple (ROE_SIMPLE)
10.36% 0.00% 3.33% -70.18% -69.39% 0.00% -73.60% 0.36% 1.29% 0.00%
Net Operating Profit after Tax (NOPAT)
18 133 0.70 -1,187 209 16 84 133 132 156
NOPAT Margin
1.86% 12.28% 0.09% -118.36% 22.44% 1.80% 9.64% 14.97% 14.76% 16.69%
Net Nonoperating Expense Percent (NNEP)
0.58% 4.19% 2.24% 29.86% 4.19% 2.15% 1.73% 2.68% 1.77% 1.71%
Return On Investment Capital (ROIC_SIMPLE)
- 1.42% - - - 0.22% - - - 2.28%
Cost of Revenue to Revenue
59.12% 55.34% 57.81% 53.14% 54.29% 53.98% 52.19% 52.76% 51.79% 52.73%
SG&A Expenses to Revenue
13.21% 15.56% 21.91% 17.15% 17.92% 18.14% 19.59% 18.15% 18.64% 18.82%
R&D to Revenue
6.60% 6.72% 9.07% 7.48% 7.62% 7.84% 8.06% 7.44% 7.81% 6.95%
Operating Expenses to Revenue
28.51% 29.65% 42.07% 215.95% 33.05% 43.45% 35.60% 32.92% 33.93% 32.62%
Earnings before Interest and Taxes (EBIT)
119 148 3.00 -1,707 111 12 109 134 123 134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
268 267 118 -1,599 212 118 205 229 217 227
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.09 1.23 1.31 2.87 2.32 2.76 3.66 3.93 3.05 3.02
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.41 1.56 1.62 1.86 1.50 1.88 2.40 2.45 2.06 1.95
Price to Earnings (P/E)
10.54 16.60 39.48 0.00 0.00 0.00 0.00 1,096.82 235.96 36.90
Dividend Yield
1.35% 1.06% 1.00% 0.82% 1.03% 0.86% 0.66% 0.67% 0.81% 0.84%
Earnings Yield
9.49% 6.02% 2.53% 0.00% 0.00% 0.00% 0.00% 0.09% 0.42% 2.71%
Enterprise Value to Invested Capital (EV/IC)
1.05 1.12 1.16 1.70 1.50 1.68 2.02 2.04 1.77 1.76
Enterprise Value to Revenue (EV/Rev)
2.68 2.69 2.75 2.95 2.56 2.96 3.46 3.58 3.18 3.02
Enterprise Value to EBITDA (EV/EBITDA)
9.85 10.26 11.73 0.00 0.00 0.00 0.00 16.76 14.64 12.34
Enterprise Value to EBIT (EV/EBIT)
13.41 15.75 22.89 0.00 0.00 0.00 0.00 34.99 29.79 21.67
Enterprise Value to NOPAT (EV/NOPAT)
17.24 20.11 27.41 0.00 0.00 0.00 0.00 48.91 19.87 20.61
Enterprise Value to Operating Cash Flow (EV/OCF)
15.99 18.04 18.83 31.31 30.29 33.64 36.61 24.16 21.13 20.52
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 12.63 10.46 11.01 19.95 15.82 14.15
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.20 1.10 1.11 1.97 1.97 1.94 1.96 2.19 2.01 1.95
Long-Term Debt to Equity
1.18 1.08 1.09 1.93 1.93 1.90 1.94 2.16 1.98 1.93
Financial Leverage
0.58 0.51 0.51 0.69 1.23 1.14 1.15 1.73 1.63 1.61
Leverage Ratio
2.28 2.18 2.14 2.49 3.10 2.96 2.95 3.83 3.73 3.69
Compound Leverage Factor
0.77 0.97 -56.40 2.61 0.61 -19.76 0.51 0.63 1.82 2.18
Debt to Total Capital
54.59% 52.36% 52.53% 66.29% 66.31% 65.96% 66.17% 68.62% 66.72% 66.15%
Short-Term Debt to Total Capital
1.04% 0.99% 0.94% 1.19% 1.18% 1.28% 0.70% 0.70% 0.69% 0.73%
Long-Term Debt to Total Capital
53.55% 51.37% 51.59% 65.10% 65.13% 64.67% 65.48% 67.91% 66.03% 65.42%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
45.41% 47.64% 47.47% 33.71% 33.69% 34.04% 33.83% 31.38% 33.28% 33.85%
Debt to EBITDA
5.69 5.30 5.84 -5.19 -4.86 -4.16 -4.46 6.39 6.25 5.17
Net Debt to EBITDA
4.68 4.32 4.80 -4.39 -4.01 -3.40 -3.66 5.28 5.13 4.36
Long-Term Debt to EBITDA
5.58 5.20 5.74 -5.09 -4.78 -4.08 -4.41 6.32 6.19 5.11
Debt to NOPAT
9.96 10.38 13.65 -4.96 -4.92 -4.40 -4.68 18.65 8.48 8.63
Net Debt to NOPAT
8.19 8.47 11.21 -4.19 -4.06 -3.60 -3.84 15.40 6.96 7.27
Long-Term Debt to NOPAT
9.77 10.19 13.41 -4.87 -4.84 -4.32 -4.63 18.46 8.39 8.54
Altman Z-Score
1.16 1.29 1.30 0.75 1.30 1.32 1.59 1.57 1.42 1.46
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.76 2.93 3.14 3.27 3.31 3.18 3.69 3.58 3.42 3.19
Quick Ratio
1.60 1.71 1.66 1.66 1.76 1.74 1.97 1.96 1.88 1.71
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-5,573 -5,705 -5,702 -4,954 1,971 2,130 2,259 513 277 396
Operating Cash Flow to CapEx
765.38% 347.17% 217.65% -347.06% 1,000.00% 532.35% 372.22% 469.23% 740.91% 345.10%
Free Cash Flow to Firm to Interest Expense
-69.66 -67.91 -67.09 -56.30 21.20 21.74 23.53 4.38 4.02 6.71
Operating Cash Flow to Interest Expense
2.49 2.19 0.44 -0.67 1.72 1.85 0.70 1.04 2.36 2.98
Operating Cash Flow Less CapEx to Interest Expense
2.16 1.56 0.24 -0.86 1.55 1.50 0.51 0.82 2.04 2.12
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.41 0.44 0.45 0.55 0.37 0.35 0.36 0.40 0.39 0.41
Accounts Receivable Turnover
5.50 6.10 6.84 6.90 5.66 5.48 6.44 5.83 5.78 5.89
Inventory Turnover
2.39 2.57 2.42 2.50 2.13 2.01 1.95 1.93 1.92 1.99
Fixed Asset Turnover
6.64 6.30 6.40 6.65 5.39 4.57 4.74 4.66 4.63 4.61
Accounts Payable Turnover
6.45 6.73 7.53 8.72 5.84 5.26 5.96 6.31 6.07 5.62
Days Sales Outstanding (DSO)
66.40 59.84 53.35 52.89 64.48 66.66 56.69 62.60 63.19 61.99
Days Inventory Outstanding (DIO)
152.56 141.80 150.73 145.95 171.28 181.39 187.58 188.71 190.52 183.08
Days Payable Outstanding (DPO)
56.61 54.20 48.49 41.88 62.51 69.41 61.20 57.84 60.12 64.91
Cash Conversion Cycle (CCC)
162.36 147.44 155.58 156.96 173.25 178.65 183.07 193.48 193.58 180.16
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
8,252 8,500 8,495 6,644 6,490 6,386 6,320 6,264 6,345 6,146
Invested Capital Turnover
0.59 0.64 0.64 0.81 0.52 0.49 0.50 0.55 0.55 0.57
Increase / (Decrease) in Invested Capital
5,591 5,838 5,703 3,767 -1,762 -2,114 -2,175 -380 -145 -240
Enterprise Value (EV)
8,636 9,545 9,887 11,304 9,753 10,730 12,776 12,806 11,262 10,834
Market Capitalization
4,533 5,528 5,843 7,155 5,739 6,816 8,880 8,775 7,315 7,010
Book Value per Share
$74.43 $67.41 $66.76 $37.37 $37.03 $36.96 $36.18 $33.23 $35.64 $34.50
Tangible Book Value per Share
($60.19) ($45.08) ($44.76) ($42.06) ($40.05) ($40.39) ($38.63) ($39.88) ($38.82) ($36.09)
Total Capital
9,137 9,410 9,376 7,402 7,350 7,261 7,166 7,115 7,206 6,860
Total Debt
4,988 4,927 4,925 4,907 4,874 4,789 4,742 4,882 4,808 4,538
Total Long-Term Debt
4,893 4,834 4,837 4,819 4,787 4,696 4,692 4,832 4,758 4,488
Net Debt
4,103 4,017 4,044 4,149 4,014 3,914 3,896 4,031 3,947 3,824
Capital Expenditures (CapEx)
26 53 17 17 16 34 18 26 22 51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
990 1,025 1,079 1,223 1,164 1,066 1,144 1,107 1,076 1,035
Debt-free Net Working Capital (DFNWC)
1,875 1,935 1,960 1,981 2,024 1,941 1,990 1,958 1,937 1,749
Net Working Capital (NWC)
1,780 1,842 1,872 1,893 1,937 1,848 1,940 1,908 1,887 1,699
Net Nonoperating Expense (NNE)
12 79 43 582 170 85 69 110 70 66
Net Nonoperating Obligations (NNO)
4,103 4,017 4,044 4,149 4,014 3,914 3,896 4,031 3,947 3,824
Total Depreciation and Amortization (D&A)
149 119 115 108 101 106 96 95 94 93
Debt-free, Cash-free Net Working Capital to Revenue
30.70% 28.90% 29.98% 31.87% 30.51% 29.43% 30.95% 30.92% 30.36% 28.86%
Debt-free Net Working Capital to Revenue
58.14% 54.55% 54.46% 51.63% 53.05% 53.59% 53.84% 54.69% 54.66% 48.77%
Net Working Capital to Revenue
55.19% 51.93% 52.01% 49.34% 50.77% 51.02% 52.49% 53.30% 53.24% 47.38%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.09 $0.57 ($0.64) ($26.47) $0.59 ($1.02) $0.22 $0.34 $0.92 $1.34
Adjusted Weighted Average Basic Shares Outstanding
61M 59.70M 66.70M 66.80M 66.90M 66.80M 67M 67.30M 67.40M 67.30M
Adjusted Diluted Earnings per Share
$0.09 $0.58 ($0.64) ($26.47) $0.58 ($1.01) $0.22 $0.33 $0.92 $1.34
Adjusted Weighted Average Diluted Shares Outstanding
61.10M 59.90M 66.70M 66.80M 67.10M 66.80M 67.40M 67.50M 67.60M 67.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
66.51M 66.67M 66.77M 66.86M 66.88M 67.06M 67.20M 67.29M 67.30M 67.38M
Normalized Net Operating Profit after Tax (NOPAT)
108 142 5.60 103 84 75 87 92 92 98
Normalized NOPAT Margin
11.30% 13.11% 0.71% 10.26% 9.01% 8.39% 10.00% 10.34% 10.31% 10.48%
Pre Tax Income Margin
4.19% 6.08% -9.95% -178.56% 2.36% -8.96% 2.19% 2.48% 6.70% 8.45%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.49 1.76 0.04 -19.40 1.19 0.12 1.14 1.15 1.78 2.27
NOPAT to Interest Expense
0.22 1.59 0.01 -13.49 2.25 0.16 0.87 1.13 1.92 2.65
EBIT Less CapEx to Interest Expense
1.16 1.13 -0.16 -19.59 1.02 -0.22 0.95 0.92 1.46 1.41
NOPAT Less CapEx to Interest Expense
-0.10 0.96 -0.19 -13.68 2.08 -0.18 0.68 0.91 1.60 1.78
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
11.16% 15.62% 37.16% -3.26% -3.43% -3.20% -3.31% 750.00% 190.32% 31.05%
Augmented Payout Ratio
11.16% 15.62% 37.16% -3.26% -3.43% -3.20% -3.31% 750.00% 190.32% 31.05%

Frequently Asked Questions About MKS Instruments' Financials

When does MKS Instruments's financial year end?

According to the most recent income statement we have on file, MKS Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MKS Instruments' net income changed over the last 9 years?

MKS Instruments' net income appears to be on a downward trend, with a most recent value of $190 million in 2024, rising from $122.30 million in 2015. The previous period was -$1.84 billion in 2023.

What is MKS Instruments's operating income?
MKS Instruments's total operating income in 2024 was $498 million, based on the following breakdown:
  • Total Gross Profit: $1.71 billion
  • Total Operating Expenses: $1.21 billion
How has MKS Instruments revenue changed over the last 9 years?

Over the last 9 years, MKS Instruments' total revenue changed from $813.52 million in 2015 to $3.59 billion in 2024, a change of 340.8%.

How much debt does MKS Instruments have?

MKS Instruments' total liabilities were at $6.27 billion at the end of 2024, a 5.7% decrease from 2023, and a 5,473.2% increase since 2015.

How much cash does MKS Instruments have?

In the past 9 years, MKS Instruments' cash and equivalents has ranged from $227.57 million in 2015 to $966 million in 2021, and is currently $714 million as of their latest financial filing in 2024.

How has MKS Instruments' book value per share changed over the last 9 years?

Over the last 9 years, MKS Instruments' book value per share changed from 21.80 in 2015 to 34.50 in 2024, a change of 58.3%.

Remove Ads


This page (NASDAQ:MKSI) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners